Cart
sales@molnova.com
Ingliforib
CAS No. 186392-65-4
Ingliforib( CP 368296 | GPi 296 )
Catalog No. M21834 CAS No. 186392-65-4
Ingliforib is a glycogen phosphorylase inhibitor, with IC50s of 52, 352 and 150 nM for liver, muscle and brain glycogen phosphorylase, and has cardioprotective activity.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 209 | In Stock |
|
| 10MG | 336 | In Stock |
|
| 25MG | 572 | In Stock |
|
| 50MG | 807 | In Stock |
|
| 100MG | 1107 | In Stock |
|
| 200MG | 1494 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameIngliforib
-
NoteResearch use only, not for human use.
-
Brief DescriptionIngliforib is a glycogen phosphorylase inhibitor, with IC50s of 52, 352 and 150 nM for liver, muscle and brain glycogen phosphorylase, and has cardioprotective activity.
-
DescriptionIngliforib is a glycogen phosphorylase inhibitor, with IC50s of 52, 352 and 150 nM for liver, muscle and brain glycogen phosphorylase, and has cardioprotective activity.
-
In Vitro——
-
In Vivo——
-
SynonymsCP 368296 | GPi 296
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number186392-65-4
-
Formula Weight457.91
-
Molecular FormulaC??H??ClN?O?
-
Purity>98% (HPLC)
-
SolubilityDMSO : 130 mg/mL (283.90 mM; Need ultrasonic)
-
SMILESO=C(C(N1)=CC2=C1C=CC(Cl)=C2)N[C@@H](CC3=CC=CC=C3)[C@@H](O)C(N4C[C@@H](O)[C@@H](O)C4)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Tracey WR, et al. Cardioprotective effects of ingliforib, a novel glycogen phosphorylase inhibitor. Am J Physiol Heart Circ Physiol. 2004 Mar;286(3):H1177-84.
molnova catalog
related products
-
VK-II-86
VK-II-86 is a non-β-blocking carvedilol analog. It prevents ouabain-Induced cardiotoxicity.
-
Jatairidoid B
The herbs of Valeriana jatamansi.
-
AZD5904
AZD5904 (AZD-5904) is a potent, selective irreversible, orally bioavailable myeloperoxidase (MPO) inhibitor with IC50 of 140 nM.
